AAP
XRAY icon

Arax Advisory Partners’s Dentsply Sirona XRAY Stock Holding History

Arax Advisory Partners’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-533
Closed -$6.09K – 4386
2025
Q4 		$6.09K Sell
533
-232,798
-100% -$2.73M ﹤0.01% 2743
2025
Q3 		$2.96M Buy
233,331
+233,175
+149,471% +$3.38M 0.04% 361
2025
Q2 		$2.48K Hold
156
– – ﹤0.01% 2490
2025
Q1 		$2.33K Sell
156
-4,451
-97% -$78.9K ﹤0.01% 2024
2024
Q4 		$87.4K Buy
4,607
+4,511
+4,699% +$95.4K 0.01% 715
2024
Q3 		$2.6K Buy
+96
New +$2.45K ﹤0.01% 1965
2022
Q4 		– Sell
-1,000
Closed -$28K – 1353
2022
Q3 		$28K Buy
+1,000
New +$34.2K ﹤0.01% 520
2018
Q3 		– Sell
-164
Closed -$7K – 744
2018
Q2 		$7K Sell
164
-63
-28% -$2.96K ﹤0.01% 372
2018
Q1 		$11K Buy
+227
New +$13.4K 0.01% 324
2017
Q3 		– Sell
-24
Closed -$2K – 500
2017
Q2 		$2K Hold
24
– – ﹤0.01% 474
2017
Q1 		$1K Hold
24
– – ﹤0.01% 524
2016
Q4 		$1K Buy
+24
New +$1.42K ﹤0.01% 537

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Arax Advisory Partners's XRAY Position: Q1 2026 in Review

Arax Advisory Partners sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 533 shares — an estimated $6.09K sold.

Arax Advisory Partners first reported a position in XRAY in Q4 2016 and held it in 12 quarters. The position peaked at $2.96M in Q3 2025. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Arax Advisory Partners reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 533 Dentsply Sirona shares in Q1 2026, an estimated $6.09K.
  • Arax Advisory Partners first reported a position in Dentsply Sirona in Q4 2016 and held it in 12 quarters.
  • Arax Advisory Partners's Dentsply Sirona position peaked at $2.96M in Q3 2025.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.